Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Statement on 30-Days’ Supply You may be interested in Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy OPA’s COVID-19 Advocacy Initiatives November 10, 2020 Post category: Advocacy Nirmatrelvir/Ritonavir (Paxlovid) Prescribing December 12, 2022 Post category: Advocacy Virtual Townhall – Symptomatic COVID-19 Testing in Pharmacies November 26, 2021 Post category: Advocacy
Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy
Virtual Townhall – Symptomatic COVID-19 Testing in Pharmacies November 26, 2021 Post category: Advocacy
